Arazlo FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 15, 2020.
FDA Approved: Yes (First approved December 18, 2019)
Brand name: Arazlo
Generic name: tazarotene
Dosage form: Lotion
Company: Bausch Health Companies Inc.
Treatment for: Acne
Arazlo (tazarotene) is a lotion formulation of the approved retinoid tazarotene for the topical treatment of acne vulgaris in patients 9 years of age and older.
Development timeline for Arazlo
| Date | Article |
|---|---|
| Dec 19, 2019 | Approval FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
